BioNTech says Novartis executive Zapata-Gomez to become CFO
Published by Global Banking & Finance Review®
Posted on May 5, 2025
1 min readLast updated: January 24, 2026
Published by Global Banking & Finance Review®
Posted on May 5, 2025
1 min readLast updated: January 24, 2026
BioNTech appoints Ramon Zapata-Gomez as its new CFO, effective July 1, succeeding Jens Holstein who retires on June 30.
(Reuters) - German COVID-19 vaccine maker BioNTech said on Monday that Ramon Zapata-Gomez will become its new finance chief from July 1.
Zapata-Gomez is currently CFO of Novartis unit Novartis BioMedical Research and will take over from Jens Holstein who, as previously announced, will retire from BioNTech on June 30.
(Reporting by Isabel Demetz and Ludwig Burger)
The main topic is the appointment of Ramon Zapata-Gomez as the new CFO of BioNTech, succeeding Jens Holstein.
Ramon Zapata-Gomez, currently CFO at Novartis BioMedical Research, will become BioNTech's new CFO.
The leadership change will take effect on July 1, following Jens Holstein's retirement on June 30.
Explore more articles in the Finance category




